课题基金 / 基金详情

Key Molecular Mechanisms of Chronic Pain Vulnerability in Women Experiencing MVC

Key Molecular Mechanisms of Chronic Pain Vulnerability in Women Experiencing MVC
经历 MVC 的女性慢性疼痛脆弱性的关键分子机制
批准号:
9896771
负责人:
Sarah Linnstaedt
金额:
$12.56万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2022-04-30

项目摘要

项目成果

Sarah Linnstaedt的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 在生活中暴露于创伤性事件是很常见的。在工业化国家,机动车碰撞(MVC)是 这是最常见的创伤类型之一,全世界每年发生超过5000万例MVC。伟大 大多数经历MVC的人没有严重的伤害;在美国,超过90%的人看到 在急诊科进行MVC评估后均出院回家。然而,很大一部分 这些人的发展慢性肌肉骨骼疼痛(MSP)。 大多数在MVC后发展为慢性MSP的人是女性。这一事实与被标记的 在其他环境中,妇女与男子相比,在中等收入国家所承受的负担有所增加。生物心理社会机制 导致这种脆弱性增加的原因仍然知之甚少,导致NIH和着名的疼痛科学家 呼吁开展更多旨在弥补这一知识差距的研究。 候选人Sarah Linnstaedt博士是一名RNA生物学家,他寻求K 01职业发展奖, 获得进行研究所需的培训,这些研究将为生物学提供重要的新见解。 机制,以及这些机制与认知/心理社会因素之间的相互作用, 导致女性慢性MSP发病。具体而言,拟议的职业发展奖将 为Linnstaedt博士提供(1)评估候选生物机制所需的知识和技能 在当代最先进的慢性MSP生物心理社会模型中, 心理社会因素,(2)进行性别特异性生物学机制的研究,以前的数据,和 候选人的试点数据,建议有助于慢性MSP的妇女,和(3)评估潜在的相互作用 生理和心理社会因素之间的联系这项工作的数据将来自收集的生物样品, 导师对MVC后慢性MSP发病机制的纵向队列研究的一部分。在颁奖结束时 在此期间,Linnstaedt博士将拥有获得R 01所需的知识、经验、技能和数据, 成为一个独立资助的翻译研究科学家,其工作解决了当前的标记 女性慢性疼痛发病率的差异。
英文摘要
Abstract Exposure to traumatic events is common in life. In industrialized nations, motor vehicle collisions (MVCs) are one of the most common types of trauma, with over 50 million MVCs occurring worldwide each year. The great majority of individuals experiencing MVC do not have serious injury; in the US more than 90% of individuals seen in the emergency department after MVC are discharged home after evaluation. However, a substantial proportion of such individuals develop chronic musculoskeletal pain (MSP). Most individuals who develop chronic MSP following MVC are women. This fact is consistent with the marked increase in MSP burden experienced by women vs. men in other settings. Biopsychosocial mechanisms responsible for this increased vulnerability remain poorly understood, leading the NIH and eminent pain scientists to call for more research aimed at addressing this knowledge gap. The candidate, Dr. Sarah Linnstaedt, is an RNA biologist who seeks a K01 career development award to gain the training necessary to perform studies that will provide important new insights into the biologic mechanisms, and the interactions between these mechanisms and cognitive/psychosocial factors, that contribute to chronic MSP pathogenesis in women. Specifically, the proposed career development award will provide Dr. Linnstaedt with the knowledge and skills necessary to (1) evaluate candidate biological mechanisms within contemporary, state-of-the-art biopsychsocial models of chronic MSP that include influential cognitive and psychosocial factors, (2) perform studies of sex-specific biological mechanisms that previous data, and the candidate’s pilot data, suggest contribute to chronic MSP in women, and (3) evaluate potential interactions between biological and psychosocial factors. Data for this work will be drawn from biologic samples collected as part of a mentor’s longitudinal cohort study of chronic MSP pathogensis after MVC. By the end of the award period, Dr. Linnstaedt will have the necessary knowledge, experience, skills, and data to obtain an R01 and become an independently-funded translational research scientist whose work addresses the current marked disparity in chronic pain incidence among women.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FKBP51 antagonism to prevent chronic pain: optimizing efficacy & evaluating safety and mechanisms
Diversity Supplement to FKBP51 antagonism to prevent chronic pain: optimizing efficacy & evaluating safety and mechanisms R01NS118563
海外基金